Course Description
Controversies in Cardiac Arrhythmias (CiCA) 2024 is designed to provide clinicians with a review of selected topics in the present-day management of patients with cardiac arrhythmias, emphasizing new advances in the field and incorporating current guidelines and evidence-based principles of practice. The format will incorporate didactic lectures, case management studies, and panel discussions.
CiCA 2024 will focus on the advances and changes in the study of cardiac arrythmias while maintaining a long-standing commitment to therapeutic innovation, evidence-based medicine and dedication to putting patients first. With the significant incidence and prevalence of cardiac arrhythmias in the United States, it is essential for healthcare professionals to stay abreast of the latest developments in this area of study.
According to the American Heart Association, cardiac arrhythmias have a substantial prevalence, with an estimated 14.4 million patients in the United States. More than 750,000 hospitalizations occur each year because of atrial fibrillation (AFib). The condition contributes to an estimated 130,000 deaths each year. The rate of AFib as the primary or a contributing cause of death has been rising for more than two decades. AFib costs the United States about $6 billion each year. Medical costs for people who have AFib are about $8,705 higher per year than for people who do not have AFib.
Target Audience
This conference is intended for cardiologists, internists, primary care physicians, physician assistants, nurse practitioners, nurses, and other health care professionals with a special interest in the evaluation, diagnosis, and management of patients with cardiac arrhythmias.
Learning Objectives
Upon completion of this activity, learners will be able to:
- Compare and contrast risks and benefits of oral anticoagulation therapy versus left atrial appendage (LAA) occlusion for the treatment of atrial fibrillation.
- Evaluate specialized pacemakers, including leadless pacing and His bundle pacing, and identify their role in arrhythmia management.
- Compare and contrast current ambulatory ECG monitoring modalities.
- Assess evidence-based clinical studies defining the importance of optimizing cardiac resynchronization therapy (CRT) for patients with congestive heart failure (CHF).
- Compare and contrast newer ablation energy sources, including cryo, laser and pulsed field, with traditional radiofrequency energy.
- Recognize patient groups at risk for developing PVC-related cardiomyopathies.
- Anticipate potential cardiac and arrhythmic complications of SARS-CoV-2 infection and therapies.
- Review the differential diagnosis of narrow and wide-QRS complex tachycardia and current therapies.
- Review current guidelines for cardiac device explanation and current extraction techniques.
- Assess evidence-based guidelines on remote monitoring of cardiac implanted electronic devices, including potential liability issues.
- Compare and contrast current intra-cardiac and extra-cardiac implantable defibrillators and review current guidelines on appropriate patient selection.
CME Accreditation
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
The Academy for Continued Healthcare Learning designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion as AAPA, AANP, and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.
Disclaimer
Guidelines require that learners in CME activities be made aware of all relevant financial relationships affecting the presentation of the faculty member. ACHL ensures that all faculty and staff involved in the planning, development, and implementation of ACHL activities disclose financial relationships held within 24 months and that relevant financial relationships are mitigated before a CME activity occurs. Complete information will be provided to learners prior to the start of the educational activity.
Event Schedule
Here is our event schedule
Friday, September 20, 2024
Morning Session
8:00 AM
Registration and Breakfast
8:25 AM
Welcoming Remarks
Edward V. Platia, MD
8:30 AM
Catheter Ablation Advances: Radiofrequency vs Cryo vs Pulsed-Field Ablation
Sung W. Lee, MD
8:50 AM
Analyzing New Atrial Fibrillation Guidelines: Role of Catheter Ablation and Other Updates
Zayd Eldadah, MD, PhD
9:15 AM
Refractory Atrial Fibrillation: New Therapies and the Role of Surgery
Christian Shults, MD
9:35 AM
Stroke Prevention in Atrial Fibrillation
Manish H. Shah, MD
10:10 AM
Break and Exhibitor Networking
10:35 AM
Leadless Pacemakers: When to Use, When to Avoid
Cyrus A. Hadadi, MD
11:00 AM
Implantable Cardiac Defibrillators: Doing Away With Intra-Cardiac Leads
Athanasios Thomaides, MD
11:25 AM
Genetics of Sudden Cardiac Death
Hillary Porter, MS, CGC
11:50 AM
Panel Discussion
Moderator: Edward V. Platia, MD
12:10 PM
Lunch – Expert Perspectives on Stroke Risk Reduction in NVAF [Non-CME]
Sponsored by Johnson and Johnson Innovative Medicine
Location: Crentz and Members Dining Rooms
Joshua S. Yamamoto, MD
Friday, September 20, 2024
Afternoon Session
1:10 PM
Conduction System Pacing and Bi-Ventricular Pacing in the Next Era: Right Patient, Right Therapy
Rajiv A. Kabadi, MD
1:50 PM
How to Manage Heart Failure Patients Using Hemodynamic Monitoring
Richa Gupta, MD, MPH
2:15 PM
New Pacing Techniques for Heart Failure
David A. Strouse, MD
2:40 PM
Ablation of Ventricular Arrhythmias: New Approaches — and When to Say No
Binaya Basyal, MD
3:05 PM
Dr. Mirowski’s Invention 40 Years Later: Today’s Implantable Defibrillator
Glenn R. Meininger, MD
3:30 PM
Artificial Intelligence in Arrhythmia Management
Apostolos Tsimploulis, MD
3:50 PM
Device Recalls: The Inside Story and What Every Clinician Should Know
CAPT Brian M. Lewis, MD
4:10 PM
Panel Discussion
Moderator: Edward V. Platia, MD
4:30 PM
Adjourn
Registration
Registration for Controversies in Cardiac Arrhythmias 2024
Click the register button to visit our secure website for updated program and registration information. We are unable to accept registrations or cancellations by telephone.
Cancellation Policy
Cancellations made in writing by August 23, 2024 will be subject to a 50% penalty. No refunds will be given after August 23, 2024. Cancellations will not be accepted by telephone. In the unlikely event that the course is canceled, we will refund the registration fee, but are not responsible for any travel costs.
Please contact us at info@cica-ep.org if you have questions or need additional information.
Exhibitors
Controversies in Cardiac Arrhythmias is a one-day program designed to provide clinicians with a review of selected topics to address the diagnosis and management of cardiac arrhythmia emphasizing new advances in the field and incorporating current guidelines and evidence-based principles of practice.
This conference will provide a forum in which practicing cardiologists, internists, primary care physicians and other health care professionals have the opportunity for effective interaction with experts in cardiac arrhythmias. Attendees will have ample opportunity during the course for face-to-face time for discussion with exhibitors and we encourage industry to bring simulators or models to provide attendees with hands–on experience with the latest technology.
Faculty
Course Directors
Zayd A. Eldadah, MD, PhD
MedStar Health
Washington, DC
Edward V. Platia, MD
MedStar Health
Washington, DC
David A. Strouse, MD
MedStar Health
Washington, DC
Binaya Basyal, MD
MedStar Health
Washington, DC
Richa Gupta, MD, MPH
MedStar Health
Washington, DC
Cyrus A. Hadadi, MD
MedStar Health
Washington, DC
Rajiv A. Kabadi, MD
MedStar Health
Washington, DC
Sung W. Lee, MD
MedStar Health
Washington, DC
CAPT Brian M. Lewis, MD
Food and Drug Administration
Potomac, MD
Glenn R. Meininger, MD
MedStar Health
Baltimore, MD
Hillary Porter, MS, CGC
MedStar Health
Washington, DC
Manish H. Shah, MD
MedStar Health
Washington, DC
Christian Shults, MD
MedStar Health
Washington, DC
Athanasios Thomaides, MD
MedStar Health
Washington, DC
Apostolos Tsimploulis, MD
MedStar Health
Washington, DC
The Cosmos Club
2121 Massachusetts Avenue, NW,
Washington, DC
Accommodations
Reservations to be made on own, the group does not have a room block. Availability is subject to the hotel